Fat tissue around internal organs releases signaling molecules that directly reduce the body's ability to respond to insulin.
See the scientific wording
Visceral adipose tissue promotes systemic insulin resistance through the secretion of pro-inflammatory cytokines and other bioactive molecules.
There's disagreement
ObservationalThe 4 studies we reviewed point in different directions — there's no clear consensus.
What the research says
4 studies reviewedSupporting (3)
Case-Control StudyHuman2026
Fat around the organs releases signals that can make the body less responsive to insulin, and this study shows that some signals from that fat (like IL-10) actually help fix that problem — proving the fat is actively sending messages that affect insulin.
Cross-Sectional StudyHuman2016
Fat around the organs releases chemicals that make the body less responsive to insulin, and this study found that one of those chemicals, TNF-α, goes up exactly when insulin resistance gets worse — even before immune cells show up.
Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue
Computational/Algorithm Study2023
Fat around the organs in obese people releases chemicals that make the body less responsive to insulin, and this study shows exactly how that happens through inflammation and immune cell changes.
Contradicting (1)
Cross-Sectional StudyHuman2019
Even though Black African men had much less belly fat than White European men, their bodies responded to insulin just as well—or poorly—in every tissue tested. This means belly fat alone doesn’t always control how well insulin works.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Fat around the organs releases chemicals like TNF-alpha and ceramides that block insulin's ability to tell cells to take up sugar. This causes sugar to build up in the blood. The fat also stops making protective molecules like adiponectin, which normally helps insulin work. These changes happen even before immune cells move in, and they spread to muscle and liver, making the whole body less responsive to insulin.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting, 1 contradicting studies
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Fat tissue around internal organs releases signaling molecules that directly reduce the body's ability to respond to insulin.
Mechanism
4 studiesFat around the organs releases chemicals that block insulin from telling cells to take in sugar. These chemicals build up inside cells and stop insulin from working, causing blood sugar to rise. This happens even before immune cells arrive, and it affects the whole body, not just the fat tissue.
Fat around the organs releases chemicals like TNF-alpha and ceramides that block insulin's ability to tell cells to take up sugar. This causes sugar to build up in the blood. The fat also stops making protective molecules like adiponectin, which normally helps insulin work. These changes happen even before immune cells move in, and they spread to muscle and liver, making the whole body less responsive to insulin.
Adipocyte hypertrophy in visceral adipose tissue increases metabolic stress and upregulates secretion of pro-inflammatory cytokines including TNF-alpha and MCP-1
TNF-alpha and other cytokines activate serine kinases that phosphorylate IRS-1 on inhibitory sites, disrupting insulin receptor signaling in adipocytes, skeletal muscle, and hepatocytes
Insulin signaling in adipocytes stimulates de novo ceramide synthesis, which further inhibits the PI3K/AKT pathway and reduces GLUT4 translocation to the cell membrane
Reduced adiponectin secretion from stressed adipocytes removes a key brake on ceramide accumulation and inflammation, allowing insulin resistance to persist
Ceramide accumulation and cytokine signaling promote polarization of macrophages toward an M1 phenotype and CD4+ T cells toward a Th17 phenotype, sustaining local inflammation
Chronic inflammation and impaired insulin signaling in visceral adipose tissue lead to systemic insulin resistance in skeletal muscle and liver, reducing glucose uptake and increasing blood glucose
Less supported by current evidence, but not ruled out
Fat tissue releases free fatty acids that build up in muscle cells, where they form toxic lipid molecules that block insulin's signal to take up sugar.
Adipose tissue lipolysis increases release of non-esterified fatty acids into circulation
Skeletal muscle takes up fatty acids and accumulates lipid intermediates such as diacylglycerol and ceramides
Lipid intermediates activate serine kinases that inhibit IRS-1, impairing insulin signaling and reducing GLUT4 translocation
Evidence from Studies
Last searched 2mo ago
Supporting (3)
Community contributions welcome
Interleukin-10 expressing B lineage cells in visceral adipose tissue protect against aging-related insulin resistance and extend lifespan
Fat around the organs releases signals that can make the body less responsive to insulin, and this study shows that some signals from that fat (like IL-10) actually help fix that problem — proving the fat is actively sending messages that affect insulin.
Fat around the organs releases chemicals that make the body less responsive to insulin, and this study found that one of those chemicals, TNF-α, goes up exactly when insulin resistance gets worse — even before immune cells show up.
Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue
Fat around the organs in obese people releases chemicals that make the body less responsive to insulin, and this study shows exactly how that happens through inflammation and immune cell changes.
Contradicting (1)
Community contributions welcome
Even though Black African men had much less belly fat than White European men, their bodies responded to insulin just as well—or poorly—in every tissue tested. This means belly fat alone doesn’t always control how well insulin works.
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Visceral Fat Mass and Insulin Resistance in Human Populations
Population: Adults with varying degrees of visceral fat; Intervention: None (observational); Comparator: Low vs. high visceral fat mass; Outcome: Insulin sensitivity measured by hyperinsulinemic-euglycemic clamp; Duration: Longitudinal follow-up of existing cohorts.
Randomized Trial of Visceral Fat Reduction via Bariatric Surgery vs. Lifestyle Intervention on Insulin Sensitivity
Population: Adults with obesity and insulin resistance; Intervention: Surgical reduction of visceral fat; Comparator: Non-surgical lifestyle intervention; Outcome: Change in insulin sensitivity via clamp; Duration: 12 months.
Prospective Cohort Study of Circulating Cytokine Levels from Visceral Fat and Incident Insulin Resistance
Population: Healthy adults without insulin resistance; Intervention: None; Comparator: High vs. low baseline cytokine profiles; Outcome: Development of insulin resistance over 5 years; Duration: 5 years.
In Vitro Exposure of Human Skeletal Muscle Cells to Visceral Adipose Tissue Secretome and Measurement of Insulin Signaling Pathway Inhibition
Population: Human primary skeletal muscle cells; Intervention: Exposure to conditioned media from human visceral adipose tissue explants; Comparator: Conditioned media from subcutaneous adipose tissue or control media; Outcome: Phosphorylation status of IRS-1 and GLUT4 translocation; Duration: 24–72 hours.
Mouse Model with Visceral Fat-Specific Cytokine Knockout and Assessment of Systemic Insulin Sensitivity
Population: Genetically modified mice with visceral fat-specific deletion of TNF-alpha and IL-6; Intervention: None; Comparator: Wild-type mice with intact cytokine secretion; Outcome: Glucose tolerance, insulin sensitivity via hyperinsulinemic-euglycemic clamp; Duration: 12 weeks.